Categories: BusinessCareDrugHealthTechManufacturingMedtechPersonalProductProductionService
Manufacturer and marketer of specialty prescription and over-the-counter (OTC) products in North America. The company also offers contract manufacturing through its production plant, located in Ontario, Canada.
Investors 3
Mentions in press and media 6
| Date | Title | Description |
| 28.04.2023 | WellSpring Consumer Healthcare Acquires Iconic OTC Skin Care Brands from Bayer | Addition of A+D® and Solarcaine® bolsters scale, product diversity, and opportunities to accelerate WellSpring’s innovation pipeline
New York, NY and Sarasota, FL – April 4, 2023 – WellSpring Consumer Healthcare, a developer and marketer o... |
| 14.08.2018 | Term Sheet — Tuesday, August 14 | THE CULTURE FUND
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
It does note that the fund, which is called “Culture” will not function like a traditional venture fund. While investors will ... |
| 09.08.2018 | Term Sheet — Thursday, August 9 | NO DEAL
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Rite Aid CEO John Standley said that the pharmacy chain had been unable to convince shareholders of the merits to the merger. Grocery g... |
| 28.09.2017 | Term Sheet — Thursday, September 28 | DIAL UP THE DRAMA
Good morning, Term Sheet readers!
Paid Content You can't secure what you can't see From ExtraHop
BITCOIN SOUND OFF: The Wolf of Wall Street has spoken. Jordan Belfort, the former stockbroker who pled guilty to fraud, calle... |
| 07.11.2011 | WellSpring Pharmaceutical Acquired by Sentinel Capital Partners | WellSpring Pharmaceutical Corporation, a Sarasota, Florida-based manufacturer and marketer of specialty prescription and over-the-counter pharmaceuticals, has been acquired by private equity firm Sentinel Capital Partners.
Ancor Capital Par... |
| 04.11.2011 | Yukon Invests in WellSpring Pharmaceutical Corp. | Yukon Partners supports Ancor Capital Partners and Sentinel Capital Partners in the acquisition of WellSpring Pharmaceutical Corp. |
Reviews 0
